CHEMOTHERAPY FOR NON-SEMINOMATOUS GERM-CELL TUMORS

被引:0
|
作者
WILKINSON, PM [1 ]
机构
[1] HOLT RADIUM INST,MANCHESTER M20 9BX,ENGLAND
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:43 / 47
页数:5
相关论文
共 50 条
  • [31] NON-SEMINOMATOUS TESTICULAR GERM-CELL TUMORS IN DENMARK 1976-1980 - RESULTS OF TREATMENT
    VONDERMAASE, H
    ENGELHOLM, SA
    RORTH, M
    NIELSEN, ES
    SCHULTZ, HP
    SVENNEKJAER, IL
    VAETH, M
    ACTA RADIOLOGICA ONCOLOGY, 1984, 23 (04): : 255 - 261
  • [32] NON-SEMINOMATOUS GERM-CELL TUMORS OF TESTIS - PROGNOSTIC VALUE OF EXTENT OF RETROPERITONEAL NODE METASTASES
    BOYLE, LE
    SAMUELS, ML
    JOHNSON, DE
    HUSSEY, DH
    HOLOYE, PY
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 267 - 267
  • [33] PROGNOSTIC FACTORS IN CLINICAL STAGE-1 NON-SEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS
    RAGHAVAN, D
    PECKHAM, MJ
    HEYDERMAN, E
    TOBIAS, JS
    AUSTIN, DE
    BRITISH JOURNAL OF CANCER, 1982, 45 (02) : 167 - 173
  • [34] SERUM FERRITIN DETERMINATIONS ARE OF NO VALUE IN THE MANAGEMENT OF PATIENTS WITH DISSEMINATED NON-SEMINOMATOUS GERM-CELL TUMORS
    OCKHUIZEN, T
    KOK, AJ
    SLEIJFER, DT
    DEBRUIJN, HWA
    KOOPS, HS
    MARRINK, J
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (08): : 931 - 934
  • [35] Association of KIT Mutations with Concurrent RAS/MAPK Pathway Driver Alterations in Seminomatous and Non-Seminomatous Germ-Cell Tumors
    Mata, Douglas
    Yang, Soo-Ryum
    Ferguson, Donna
    Liu, Ying
    Sharma, Rohit
    Al-Ahmadie, Hikmat
    Solit, David
    Feldman, Darren
    Tickoo, Satish
    Reuter, Victor
    Arcila, Maria
    Ladanyi, Marc
    Vanderbilt, Chad
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 931 - 933
  • [36] Non-seminomatous germ-cell tumour associated with acute megakaryoblastic leukaemia
    D. Dopico Vázquez
    M. I. Gallegos Sancho
    G. Alonso Curbera
    A. Carral Maseda
    M. Quindós Varela
    L. M. Antón Aparicio
    Clinical and Translational Oncology, 2007, 9 : 329 - 331
  • [37] Association of KIT Mutations with Concurrent RAS/MAPK Pathway Driver Alterations in Seminomatous and Non-Seminomatous Germ-Cell Tumors
    Mata, Douglas
    Yang, Soo-Ryum
    Ferguson, Donna
    Liu, Ying
    Sharma, Rohit
    Al-Ahmadie, Hikmat
    Solit, David
    Feldman, Darren
    Tickoo, Satish
    Reuter, Victor
    Arcila, Maria
    Ladanyi, Marc
    Vanderbilt, Chad
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 931 - 933
  • [38] Non-seminomatous germ-cell tumour associated with acute megakaryoblastic leukaemia
    Vazquez, D. Dopico
    Sancho, M. I. Gallegos
    Curbera, G. Alonso
    Maseda, A. Carral
    Varela, M. Quindos
    Aparicio, L. M. Anton
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2007, 9 (05): : 329 - 331
  • [39] The management of poor-prognosis, non-seminomatous germ-cell tumours
    Sirohi, B
    Huddart, R
    CLINICAL ONCOLOGY, 2005, 17 (07) : 543 - 552
  • [40] Patients with advanced non-seminomatous germ-cell tumour: the art of the start
    Honecker, F.
    Bokemeyer, C.
    ANNALS OF ONCOLOGY, 2010, 21 (08) : 1569 - 1571